A ranar 15 ga Disamba, 2025, Hukumar Kula da Kayayyakin Lafiya ta Ƙasa ta China ta amince da ƙaddamar da sabuwar maganin hana cutar kansa ta zurletrectinib (ICP-723) a hukumance. Wannan gagarumin ci gaba ya kawo begen magani ga marasa lafiya a duk duniya waɗanda ke ɗauke da ƙwayoyin cuta masu ƙarfi waɗanda ke ɗauke da kwayoyin halittar haɗin NTRK.
**Maganin Juyin Juya Hali na "Ƙwayar da ba ta da alaƙa da ƙari": Nasarar Kimiyya ta Zurletrectinib**
Zurletrectinib shine maganin hana TRK na farko da aka ƙirƙira a China wanda aka ƙera shi da kansa, wanda aka ƙera musamman ga marasa lafiya da ke da ciwace-ciwacen da suka yi tsanani a cikin gida ko kuma waɗanda ke ɗauke da kwayoyin halittar haɗin gwiwar Neurotrophic Tyrosine Receptor Kinase (NTRK). Wannan maganin hana ciwon daji mai faɗi "ƙaramin ƙari" yana wakiltar wani canji a fannin maganin ciwon daji - yana canzawa daga rarrabuwa da magani na gargajiya bisa tushen wurin asali zuwa magani mai inganci bisa ga sauye-sauyen kwayoyin halitta.
**Mahimman Alamomi:**
* Marasa lafiya da aka gano ta hanyar gwajin da aka tabbatar da ingancinsa a matsayin suna ɗauke da kwayar halittar NTRK (ban da sanannun maye gurbi da aka samu na juriya).
* Manya da matasa marasa lafiya (shekaru 12 zuwa sama) masu ciwon daji masu ƙarfi waɗanda ba su da wani magani mai gamsarwa ko kuma waɗanda maganinsu na baya ya gaza.
**Asalin Amfani:**
Muddin an gano kwayar halittar NTRK ta hanyar gwajin kwayoyin halitta, marasa lafiya na iya amfana sosai daga maganin zurletrectinib, ko ciwon ya samo asali ne daga huhu, thyroid, nono, hanji, ko wasu wurare.
**Bayanan Asibiti Masu Kyau: Sake Bayyana Tsokacin Magani**
Gwaje-gwajen asibiti na zurletrectinib da aka gudanar a kasar Sin sun nuna kyakkyawan sakamako, suna ba da kyakkyawan fata ga marasa lafiya da ke fama da ciwon daji mai tsanani:
* **Jimillar Amsar da Aka Bayar (ORR): 89.1%** — Kusan kashi 90% na marasa lafiya sun fuskanci raguwar ƙari mai yawa.
* **Matsakaicin Kula da Cututtuka (DCR): 96.4%** — An shawo kan ci gaban cututtuka yadda ya kamata a kusan dukkan marasa lafiya.
* **Yawan Rayuwa Ba Tare Da Ci Gaba Ba (PFS) na Watanni 24: 77.4%** — Kula da ci gaban cututtuka na dogon lokaci.
* **Jimillar watanni 24 na Jimlar Rayuwa (OS): 90.8%** — Tsawon lokacin da majiyyaci zai iya rayuwa sosai.
**Sashen Kasa da Kasa na Asibitin Oncology na Yankin Kudu na Beijing: Hanyarku ta Maganin Ciwon Daji Mai Kyau**
Sashen Kula da Cututtukan Cututtuka na Ƙasa da Ƙasa na Asibitin Birnin Beijing na Kudu ya himmatu wajen samar wa marasa lafiya na duniya hanyoyin samun hanyoyin magance cutar kansa. Ƙungiyar likitocinmu ta ƙasa da ƙasa ta himmatu wajen bayar da cikakken tallafin likita ga kowane majiyyaci na ƙasashen duniya.
Ayyukanmu na musamman sun haɗa da:
1. Shawarwari da kimantawa kan kula da marasa lafiya na ƙasashen duniya.
2. Shiryawa da fassara gwajin haɗakar kwayoyin halitta na NTRK.
3. Shawarwari daga kwararru daban-daban da kuma cikakken tsarin magani.
4. Tallafin fassara da al'adu da harsuna da yawa.
**Tuntuɓi Sashen Ƙasa da Ƙasa na Asibitin Cutar Kanjamau na Yankin Kudu na Beijing**
Mun fahimci sarkakiya da ƙalubalen da marasa lafiya na ƙasashen duniya ke fuskanta lokacin da suke neman kulawar likita a ƙasashen waje. Saboda haka, mun kafa hanyoyin sadarwa masu dacewa da bambance-bambance don tabbatar da cewa za ku iya samun damar samun bayanai masu ƙarfi da kuma fara tsarin magani cikin sauƙi.
**Hanyar Hulɗa da Aka Fi So:**
* Layin Sadarwa na Marasa Lafiya na Ƙasashen Duniya: 400-880-3716
**Tashoshin Sadarwa Iri-iri:**
* Shawarwari na WeChat: Ƙara ID "17801183037" don shawarwari bisa ga saƙo da kuma amsa cikin sauri.
* Shawarwari ta Imel:
* General Inquiry: 100085_010@163.com
* International Medical Exclusive: myimmnet@163.com
**Tsarin Marasa Lafiya na Ƙasashen Duniya:**
1. Tuntuɓi Mai Kula da Marasa Lafiya na Ƙasashen Duniya ta kowace hanya da ke sama.
2. Aika bayanan likita don tantancewa ta farko (gami da rahotannin cututtukan jiki, sakamakon gwajin kwayoyin halitta, da sauransu).
3. Yi jadawalin tattaunawa ta bidiyo daga nesa da ƙwararren masanin cutar kansa na duniya.
4. Idan ana buƙatar magani a China, za mu taimaka wajen sarrafa bizar likita, shirye-shiryen masauki, da sauran dabaru.
5. Ji daɗin ayyukan likita na tsayawa ɗaya bayan isowa Beijing, tun daga ɗaukar jirgin sama zuwa dukkan tafiyar magani.
**Muhimmin Tunatarwa: Gwajin Halitta Kafin A Yi Magani Yana Da Muhimmanci**
A matsayin magani da aka yi niyya, ingancin zurletrectinib ya dogara sosai akan gwajin kwayoyin halitta mai inganci. Muna ba da shawarar duk marasa lafiya da ke tunanin wannan maganin su fara gwajin kwayar halittar NTRK. Sashen Kasa da Kasa na Asibitin Oncology na Yankin Kudu maso Yammacin Beijing zai iya shirya muku ayyukan gwaji na duniya ko kuma ya ba ku fassarar da ta dace game da sakamakon gwajin da kuke da shi.
**Duba Gaba: Sabon Zamani na Maganin Ciwon Daji na Keɓancewa**
Amincewar zurletrectinib ba wai kawai ƙaddamar da wani sabon magani ba ne; shaida ce mai ƙarfi ga ƙarfin da China ke da shi a fannin maganin cutar kansa. Sashen Ƙasa da Ƙasa na Asibitin Oncology na Yankin Kudu maso Gabashin Beijing zai ci gaba da bin diddigin ci gaban da aka samu a duniya a fannin maganin cutar kansa, haɗa albarkatun lafiya masu inganci daga tushe na cikin gida da na ƙasashen waje, da kuma samar da ayyukan gano cutar kansa da kuma kula da marasa lafiya na duniya, waɗanda suka mayar da hankali kan cutar kansa.
**Kira yanzu don tambaya ko kai ko ƙaunataccenka yana cikin waɗanda za su yi wannan sabuwar hanyar magani!**
Layin Sadarwa na Marasa Lafiya na Ƙasashen Duniya na Asibitin Oncology na Yankin Kudu na Beijing: 400-880-3716
Shaidar WeChat: 17801183037
Email: 100085_010@163.com; myimmnet@163.com
**Lura:** Bayanan likita da ke cikin wannan labarin sun dogara ne akan bayanan gwaji na asibiti da jama'a ke samu. Dole ne kwararrun likitoci su tsara takamaiman tsare-tsaren magani bisa ga yanayin kowane majiyyaci. Ana ba da shawarar duk marasa lafiya su tuntuɓi ƙwararrun ma'aikatan kiwon lafiya kafin su yi la'akari da kowace magani.
Lokacin Saƙo: Disamba-31-2025